French Guiana Entertainment Bulletin
SEE OTHER BRANDS

The latest arts and entertainment news from French Guiana

Syndromic Multiplex Diagnostics Market Projected to Reach $4.96 Billion with 9.7% CAGR by 2029

The Business Research Company

The Business Research Company

The Business Research Company's Syndromic Multiplex Diagnostics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, September 15, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Syndromic Multiplex Diagnostics Market Through 2025?
The market size for syndromic multiplex diagnostics has significantly expanded in the past few years. Expectations are that it will escalate from $3.11 billion in 2024 to $3.43 billion in 2025, presenting a compound annual growth rate (CAGR) of 10.0%. The remarkable growth in the historic period is due to factors such as the surging demand for swift and precise diagnostics, heightened consciousness about the importance of early disease detection, an increase in hospital-acquired infections, wider acceptance of molecular diagnostics, a rise in healthcare expenditure, and a growing necessity for point-of-care testing.

In the coming years, the syndromic multiplex diagnostics market is projected to experience significant expansion, reaching an estimated worth of $4.96 billion by 2029 at a compound annual growth rate (CAGR) of 9.7%. The substantial growth during the forecast period can be linked to factors such as the surge in research and development investments, increased use in low-resource environments, improving healthcare infrastructure in emerging nations, governmental initiatives aimed at controlling infectious diseases, and a rising demand for localized testing. The forecast period will also witness several prominent trends, including advancements in multiplex polymerase chain reaction (PCR) technologies, innovations in microfluidics and lab-on-chip systems, the advent of advanced automation in sample processing, the emergence of innovative point-of-care molecular platforms, the adoption of cloud-based diagnostic data systems, and progress in handheld diagnostic equipment.

Download a free sample of the syndromic multiplex diagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27427&type=smp

What Are The Key Factors Driving Growth In The Syndromic Multiplex Diagnostics Market?
The rising instance of infectious diseases is anticipated to stimulate the expansion of the syndromic multiplex diagnostics market. These infectious diseases are ailments brought about by damaging microorganisms like bacteria, viruses, fungi, or parasites which proliferate within the body leading to health issues. The escalation in these diseases is primarily due to increased globalization and travel, which facilitate the swift spread of pathogens across different regions and communities. Syndromic multiplex diagnostics offer an advantage in managing these diseases by allowing the swift and simultaneous detection of numerous pathogens from a single specimen, thereby enhancing the accuracy and speed of diagnosis. This helps in formulating quick treatment strategies, ultimately leading to improved patient outcomes. As an illustration, the Centers for Disease Control and Prevention, a US-based national health body, reported 8,331 tuberculosis (TB) cases in March 2023, an escalation of 5.9% from the 7,874 cases observed in 2022. Consequently, the increasing instance of infectious diseases is fueling the expansion of the syndromic multiplex diagnostics market.

What Are The Top Players Operating In The Syndromic Multiplex Diagnostics Market?
Major players in the Syndromic Multiplex Diagnostics Global Market Report 2025 include:

• Roche Molecular Systems Inc.
• Abbott Laboratories
• Becton Dickinson and Company
• Hologic Inc.
• Bio‑Rad Laboratories Inc.
• Qiagen N.V.
• Cepheid
• Bosch Healthcare Solutions GmbH
• Biocartis NV
• Luminex Corporation

What Are The Key Trends And Market Opportunities In The Syndromic Multiplex Diagnostics Sector?
Leading firms in the syndromic multiplex diagnostics market are striving to create technological solutions that are at the cutting edge, with AI-enhanced diagnostic algorithms being a key focus. They aim to improve the pace, precision, and breadth of pathogen detection through these advancements. These diagnostic algorithms, enriched with AI, use sophisticated computational tools that utilize machine learning and deep learning strategies to decipher intricate clinical and laboratory data, leading to more timely and precise disease diagnoses. For example, the molecular diagnostics corporation from the Netherlands, Qiagen N.V., unveiled two syndromic testing panels in January 2024 - the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel - for their QIAstat Dx platform. These panels allow quicker and more precise diagnosis of infectious illnesses by identifying multiple pathogens via a single test, which enhances clinical decision-making and patient results. The QIAstat-Dx system is equipped with superior data analytics, assisting healthcare experts in promptly recognizing and handling infectious disease epidemics.

Comprehensive Segment-Wise Insights Into The Syndromic Multiplex Diagnostics Market
The syndromic multiplex diagnostics market covered in this report is segmented

1) By Product Type: Instruments, Reagents, Software And Services
2) By Sample Type: Blood Samples, Urine Samples, Saliva Samples, Tissue Samples
3) By Technology: Polymerase Chain Reaction, Mass Spectrometry, Nucleic Acid Amplification Tests, Next-Generation Sequencing
4) By Application: Infectious Diseases, Respiratory Diseases, Gastrointestinal Diseases, Sexually Transmitted Infections, Central Nervous System Diseases
5) By End User: Clinical Laboratories, Hospitals, Pharmaceutical And Biotechnology Companies, Research Institutes, Other End Users

Subsegments:
1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems, Microfluidic-Based Systems, Automated Sample-To-Answer Systems, Cartridge-Based Systems, Multiplex Polymerase Chain Reaction (PCR) Platforms
2) By Reagents: Assay Panels, Primers And Probes, Enzymes, Buffers And Solutions, Sample Preparation Reagents
3) By Software And Services: Data Analysis Software, Cloud-Based Diagnostic Platforms, Integration And Connectivity Solutions, Technical Support Services, Maintenance And Calibration Services, Training And Installation Services

View the full syndromic multiplex diagnostics market report:
https://www.thebusinessresearchcompany.com/report/syndromic-multiplex-diagnostics-global-market-report

Global Syndromic Multiplex Diagnostics Market - Regional Insights
In the Syndromic Multiplex Diagnostics Global Market Report 2025, North America held the topmost position for the year 2024. The region anticipated to experience the quickest growth is Asia-Pacific. The report examines the following regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Reports Similar to the Global Syndromic Multiplex Diagnostics Market 2025, By The Business Research Company

Scissor Lift Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/scissor-lift-global-market-report

Artificial Lift System Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/artificial-lift-system-global-market-report

Vertical Mast Lifts Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vertical-mast-lifts-global-market-report

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions